Amphastar Taps Private Financing After Major Eli Lilly Acquisition
US-Based Firm Looks To Raise Hundreds Of Millions After Splashing Out On Brand
Amphastar is looking to tidy up its balance sheet after the company’s landmark acquisition of Eli Lilly’s Baqsimi (glucagon) emergency nasal spray.
